Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FDAOncology: #FDAOncology article via @JNCI_Now provides an update on oncology/hematology drug approvals from 2008 to 2016, with… https://t.co/yiAIR2WwTM

RT @ZacharyBrennan: FDA's CBER really going after websites selling unapproved HIV test kits - 2 more untitled letters released today (4… https://t.co/Oqtv2rC8UG

RT @US_FDA: Help the drug development community continue progress against cancer. We want your input on FDA’s new draft guidanc… https://t.co/kgRl3dNmiq

RT @FDASpox: #FDA plays an integral part in the global fight against flu. Today, we announced an upcoming advisory committee to… https://t.co/OMG5i47if3

RT @FDAOncology: New blog post by #FDAOncology Director Richard Pazdur, MD, on our draft #ExpansionCohorts guidance for cancer… https://t.co/pAOWKIeG8d

RT @FDA_Track: Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible #opioid… https://t.co/5zhXKVJ0dA

RT @FDAOncology: Join us Sept. 6 for FDA-AACR Workshop on Non-clinical Models for Safety Assessment of Immuno-oncology Products… https://t.co/nsmkEPPSrX

RT @FDASpox: #FDA is continuing its commitment to support farmers in implementing the new produce safety standards under #FSMA.… https://t.co/iMUt6oU6st

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA on advancing the science and regulation of live microbiome-based prod… https://t.co/VSpp1U1KHQ

Today #FDA announced new initiatives to more efficiently identify potential safety issues for medical devices and prioritize our resources on devices that pose a higher risk to public health. https://t.co/KfA2gYsZEl

#FDA is committed to the development of generic versions of complex drugs once patents and exclusivities have lapsed on innovator products. We’ve made significant investments in new policies to facilitate these opportunities for patients, to promote access https://t.co/2Gd5l09F3C

An approved generic epinephrine auto-injector means patients should have a lower cost option and another product to help protect against potential drug shortages, promote competition, secure access https://t.co/AqyaFMLWZ9

RT @FDA_Track: Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing the science and regulation of live microbiome-ba… https://t.co/zrkTNEo5e3

Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our commitment to making lower cost, safe, and effective generic alternatives available to patients. https://t.co/D2xkAYFKKQ

RT @C_Garthwaite: This is how we bring down drug prices -- with competition. https://t.co/xULf4kK7nn QT @SGottliebFDA: Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. i… https://t.co/NAoq9LVQjY)

RT @FDASpox: Read @SGottliebFDA’s statement on a new analysis of significant public health value & cost savings resulting from… https://t.co/kddBAZ4D5N

RT @FDA_Drug_Info: #FDAapproves first generic version of EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors:… https://t.co/WZH1nQZOeK

The #FDA appreciates our collaboration with @facebook and the work they are doing with our agency, and through their independent steps, to address the sale of illicit opioid drugs on the Internet. https://t.co/3uxRcqxTgN

#FDA staff are committed to our mission of protecting & promoting public health and keeping the public well-informed about our actions. Despite their snarky survey today, I trust @medpagetoday and its staff welcome our commitment to transparency, appreciate openness in government

RT @tmprowell: Try again, @medpagetoday survey. How about: Do #FDA employees work incredibly hard to improve & safeguard the heal… https://t.co/kvSrn3Ny7i

RT @FDAOncology: #FDAOncology article via @JNCI_Now provides an update on oncology/hematology drug approvals from 2008 to 2016, with… https://t.co/yiAIR2WwTM

RT @ZacharyBrennan: FDA's CBER really going after websites selling unapproved HIV test kits - 2 more untitled letters released today (4… https://t.co/Oqtv2rC8UG

RT @US_FDA: Help the drug development community continue progress against cancer. We want your input on FDA’s new draft guidanc… https://t.co/kgRl3dNmiq

RT @FDASpox: #FDA plays an integral part in the global fight against flu. Today, we announced an upcoming advisory committee to… https://t.co/OMG5i47if3

RT @FDAOncology: New blog post by #FDAOncology Director Richard Pazdur, MD, on our draft #ExpansionCohorts guidance for cancer… https://t.co/pAOWKIeG8d

RT @FDA_Track: Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible #opioid… https://t.co/5zhXKVJ0dA

RT @FDAOncology: Join us Sept. 6 for FDA-AACR Workshop on Non-clinical Models for Safety Assessment of Immuno-oncology Products… https://t.co/nsmkEPPSrX

RT @FDASpox: #FDA is continuing its commitment to support farmers in implementing the new produce safety standards under #FSMA.… https://t.co/iMUt6oU6st

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA on advancing the science and regulation of live microbiome-based prod… https://t.co/VSpp1U1KHQ

Today #FDA announced new initiatives to more efficiently identify potential safety issues for medical devices and prioritize our resources on devices that pose a higher risk to public health. https://t.co/KfA2gYsZEl

#FDA is committed to the development of generic versions of complex drugs once patents and exclusivities have lapsed on innovator products. We’ve made significant investments in new policies to facilitate these opportunities for patients, to promote access https://t.co/2Gd5l09F3C

An approved generic epinephrine auto-injector means patients should have a lower cost option and another product to help protect against potential drug shortages, promote competition, secure access https://t.co/AqyaFMLWZ9

RT @FDA_Track: Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing the science and regulation of live microbiome-ba… https://t.co/zrkTNEo5e3

Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our commitment to making lower cost, safe, and effective generic alternatives available to patients. https://t.co/D2xkAYFKKQ

RT @C_Garthwaite: This is how we bring down drug prices -- with competition. https://t.co/xULf4kK7nn QT @SGottliebFDA: Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. i… https://t.co/NAoq9LVQjY)

RT @FDASpox: Read @SGottliebFDA’s statement on a new analysis of significant public health value & cost savings resulting from… https://t.co/kddBAZ4D5N

RT @FDA_Drug_Info: #FDAapproves first generic version of EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors:… https://t.co/WZH1nQZOeK

The #FDA appreciates our collaboration with @facebook and the work they are doing with our agency, and through their independent steps, to address the sale of illicit opioid drugs on the Internet. https://t.co/3uxRcqxTgN

#FDA staff are committed to our mission of protecting & promoting public health and keeping the public well-informed about our actions. Despite their snarky survey today, I trust @medpagetoday and its staff welcome our commitment to transparency, appreciate openness in government

RT @tmprowell: Try again, @medpagetoday survey. How about: Do #FDA employees work incredibly hard to improve & safeguard the heal… https://t.co/kvSrn3Ny7i